Provided by Tiger Trade Technology Pte. Ltd.

HBM HOLDINGS-B

13.440
-0.420-3.03%
Volume:4.01M
Turnover:53.04M
Market Cap:11.68B
PE:122.18
High:13.670
Open:13.620
Low:12.890
Close:13.860
52wk High:17.070
52wk Low:9.460
Shares:869.00M
HK Float Shares:869.00M
Volume Ratio:0.41
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.110
ROE:23.97%
ROA:10.88%
PB:3.56
PE(LYR):122.18
PS:8.31

Loading ...

HBM HOLDINGS-B Independent Director Under Investigation by Chinese Securities Regulator

Stock News
·
May 13

HBM Holdings Independent Director Faces CSRC Probe; Board Affirms Normal Operations

Bulletin Express
·
May 13

Hbm Holdings - Board States Investigation Will Not Affect Group's Normal Operations

THOMSON REUTERS
·
May 13

Hbm Holdings - Independent Non-Executive Director Receives Case Filing Notice From Csrc on 12 May 2026

THOMSON REUTERS
·
May 13

HBM Holdings completes HK$3.97 million share buyback and issues 72,000 new shares under award scheme

Bulletin Express
·
May 12

HBM Holdings files HKEX return disclosing share buyback at HKD 13.22 each

Reuters
·
May 12

HBM Holdings (SEHK:2142) Valuation Check After FDA Green Light For HBM7004 Phase I Trial

Simply Wall St.
·
May 12

HBM HOLDINGS-B (02142) Repurchases 164,000 Shares for HK$2,144,100 on May 11

Stock News
·
May 11

HBM's Anti-Tumor Drug Application Gets FDA Clearance for Phase 1 Trial

MT Newswires Live
·
May 08

HBM Holdings trims free float via HKD 3.97 million buy-back, issues 44,000 award shares

Bulletin Express
·
May 08

HBM HOLDINGS-B (02142) Spends HK$3.97 Million on Share Buyback on May 8

Stock News
·
May 08

HBM Holdings files HKEX disclosure, repurchases shares at HKD 13.24 each

Reuters
·
May 08

HBM HOLDINGS-B Receives FDA Clearance for HBM7004 Investigational New Drug Application

Stock News
·
May 08

HBM Holdings Receives FDA IND Clearance for HBM7004 Bispecific Antibody Targeting Advanced Solid Tumors

Bulletin Express
·
May 08

Harbour Biomed Announces U.S. FDA Ind Clearance for Hbm7004 for the Treatment of Advanced Solid Tumors

THOMSON REUTERS
·
May 08

HBM Holdings wins US FDA IND clearance for HBM7004 solid tumor trial

Reuters
·
May 08

Leadership Reshuffle Sweeps Pharmaceutical Sector: Hengrui, Fosun, AstraZeneca, Pfizer Among Key Players

Deep News
·
May 07

HBM Holdings Updates Capital Structure: 0.03 Million-Share Buyback, 0.05 Million New Shares Issued for Awards

Bulletin Express
·
May 07

HBM HOLDINGS-B (02142) Repurchases 800,000 Shares for HK$10.27 Million on May 6

Stock News
·
May 06

HBM Holdings files HKEX disclosure return, reports share repurchase at HKD 12.84 each

Reuters
·
May 06